rs759584454
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 5P and 2B. PM1PM2PP2BP4_Moderate
The NM_000335.5(SCN5A):c.2963G>A(p.Arg988Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,610,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.2963G>A | p.Arg988Gln | missense_variant | Exon 17 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.2963G>A | p.Arg988Gln | missense_variant | Exon 17 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.2963G>A | p.Arg988Gln | missense_variant | Exon 17 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.2963G>A | p.Arg988Gln | missense_variant | Exon 17 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000726 AC: 11AN: 151602Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000502 AC: 12AN: 238940Hom.: 0 AF XY: 0.0000383 AC XY: 5AN XY: 130458
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1458668Hom.: 0 Cov.: 36 AF XY: 0.0000152 AC XY: 11AN XY: 725404
GnomAD4 genome AF: 0.0000726 AC: 11AN: 151602Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 9AN XY: 74034
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 988 of the SCN5A protein (p.Arg988Gln). This variant is present in population databases (rs759584454, gnomAD 0.02%). This missense change has been observed in individuals with Brugada syndrome or dilated cardiomyopathy (PMID: 28341781; internal data). ClinVar contains an entry for this variant (Variation ID: 201551). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant disrupts the p.Arg988 amino acid residue in SCN5A. Other variant(s) that disrupt this residue have been observed in individuals with SCN5A-related conditions (PMID: 23321620), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Identified in association with Brugada syndrome and epilepsy in published literature (PMID: 31696929, 32893267, 28341781); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28341781, 32893267, 31696929, 24190697) -
Cardiac arrhythmia Uncertain:2
This missense variant replaces arginine with glutamine at codon 988 of the SCN5A protein. Computational prediction tool suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with arrhythmia (PMID: 24190697, 28341781). This variant has been identified in 13/267090 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This missense variant replaces arginine with glutamine at codon 988 of the SCN5A protein. Computational prediction tool suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <=0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with arrhythmia (PMID: 24190697, 28341781). This variant has been identified in 13/267090 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
- -
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.R988Q variant (also known as c.2963G>A), located in coding exon 16 of the SCN5A gene, results from a G to A substitution at nucleotide position 2963. The arginine at codon 988 is replaced by glutamine, an amino acid with highly similar properties. This variant has been detected in cohorts of patients reported to have Brugada syndrome or Long QT syndrome; however, clinical details were limited (Gómez J et al. J Cardiovasc Transl Res, 2014 Feb;7:133-7; Yamagata K et al. Circulation, 2017 Jun;135:2255-2270; Walsh R et al. Genet Med, 2021 Jan;23:47-58). This variant has also been detected in a cohort undergoing genetic testing for suspected epilepsy and unspecified phenotype (Li X et al. Ann Hum Genet, 2020 Mar;84:161-168). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at